NOC2L Polyclonal Antibody
- Catalog No.:YT3160
- Applications:WB;IHC;IF;ELISA
- Reactivity:Human;Mouse;Rat
- Target:
- NOC2L
- Gene Name:
- NOC2L
- Protein Name:
- Nucleolar complex protein 2 homolog
- Human Gene Id:
- 26155
- Human Swiss Prot No:
- Q9Y3T9
- Mouse Swiss Prot No:
- Q9WV70
- Immunogen:
- The antiserum was produced against synthesized peptide derived from human NOC2L. AA range:602-651
- Specificity:
- NOC2L Polyclonal Antibody detects endogenous levels of NOC2L protein.
- Formulation:
- Liquid in PBS containing 50% glycerol, 0.5% BSA and 0.02% sodium azide.
- Source:
- Polyclonal, Rabbit,IgG
- Dilution:
- WB 1:500 - 1:2000. IHC 1:100 - 1:300. ELISA: 1:40000.. IF 1:50-200
- Purification:
- The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen.
- Concentration:
- 1 mg/ml
- Storage Stability:
- -15°C to -25°C/1 year(Do not lower than -25°C)
- Other Name:
- NOC2L;NIR;Nucleolar complex protein 2 homolog;Protein NOC2 homolog;NOC2-like protein;Novel INHAT repressor
- Observed Band(KD):
- 85kD
- Background:
- NOC2 like nucleolar associated transcriptional repressor(NOC2L) Homo sapiens Histone modification by histone acetyltransferases (HAT) and histone deacetylases (HDAC) can control major aspects of transcriptional regulation. NOC2L represents a novel HDAC-independent inhibitor of histone acetyltransferase (INHAT) (Hublitz et al., 2005 [PubMed 16322561]).[supplied by OMIM, Mar 2008],
- Function:
- similarity:Belongs to the NOC2 family.,
- Subcellular Location:
- Nucleus, nucleoplasm. Nucleus, nucleolus. Translocates from the nucleoli to the nucleoplasm in presence of several stressors like ultraviolet irradiation and actinomycin-D. Predominantly detected in the nucleoli in non-mitotic cells. Predominantly detected in nucleoplasma in cells undergoing mitosis.
- Expression:
- Brain,Epithelium,Placenta,
Age-Associated Proteomic Signatures and Potential Clinically Actionable Targets of Colorectal Cancer. MOLECULAR & CELLULAR PROTEOMICS Mol Cell Proteomics. 2021 Jan;20:100115 WB Human 1:2000 Colorectal cancer (CRC) tissues HT29,HCT116
- June 19-2018
- WESTERN IMMUNOBLOTTING PROTOCOL
- June 19-2018
- IMMUNOHISTOCHEMISTRY-PARAFFIN PROTOCOL
- June 19-2018
- IMMUNOFLUORESCENCE PROTOCOL
- September 08-2020
- FLOW-CYTOMEYRT-PROTOCOL
- May 20-2022
- Cell-Based ELISA│解您多样本WB检测之困扰
- July 13-2018
- CELL-BASED-ELISA-PROTOCOL-FOR-ACETYL-PROTEIN
- July 13-2018
- CELL-BASED-ELISA-PROTOCOL-FOR-PHOSPHO-PROTEIN
- July 13-2018
- Antibody-FAQs
- Products Images
- Gong, Yanqiu, et al. "Age-Associated Proteomic Signatures and Potential Clinically Actionable Targets of Colorectal Cancer." Molecular & Cellular Proteomics (2021): 100115.
- Western blot analysis of lysates from MCF-7 cells, using NOC2L Antibody. The lane on the right is blocked with the synthesized peptide.